Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Md Shahidul, Ahsan"'
Autor:
Hamzah Babkair, Manabu Yamazaki, Satoshi Maruyama, Md. Shahidul Ahsan, Wael Swelam, Tatsuya Abé, Jun Cheng, Takashi Saku, Yoshimasa Sumita, Md. Shihab Uddin, Ahmed Essa
Publikováno v:
Human Pathology. 57:51-60
We reported that altered cell contact mediated by E-cadherin is an initial event in the pathogenesis of oral epithelial malignancies. To assess other effects of cell adhesion, we examined the expression levels of tight junction (TJ) molecules in oral
Autor:
Masayuki Tsuneki, Jun Cheng, Mayumi Hasegawa, Satoshi Maruyama, Takashi Saku, Kamal Al-Eryani, Md. Shahidul Ahsan, Manabu Yamazaki
Publikováno v:
Microscopy Research and Technique. 74:264-268
For histopathological assessment of oral borderline malignancies, it is important to carefully detect subtle epithelial changes on fully stretched tissue sections. However, it is not generally easy to obtain wrinkle-free sections when using formalin-
Autor:
Henry Ademola A, Jun Cheng, Mayumi Hasegawa, Takashi Saku, Takanori Kobayashi, Hiroko Ida-Yonemochi, Manabu Yamazaki, Satoshi Maruyama, Md. Shahidul Ahsan
Publikováno v:
Journal of Oral Pathology & Medicine. 40:552-559
J Oral Pathol Med (2011) 40: 552–559 Objectives: The deposition of perlecan, a heparan sulfate proteoglycan, is enhanced within oral carcinoma in situ (CIS) foci, while it dynamically switches from CIS foci to the stromal space in squamous cell car
Publikováno v:
Histopathology. 58(2)
Intercellular deposition of perlecan, an extracellular matrix molecule, results in characteristic stellate reticulum-like structures in ameloblastomas. The aims of this study were to elucidate which types of perlecan receptors function within any par
Autor:
Md Shahidul, Ahsan, Manabu, Yamazaki, Satoshi, Maruyama, Takanori, Kobayashi, Hiroko, Ida-Yonemochi, Mayumi, Hasegawa, Adeola, Henry Ademola, Jun, Cheng, Takashi, Saku
Publikováno v:
Journal of oral pathologymedicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology. 40(7)
The deposition of perlecan, a heparan sulfate proteoglycan, is enhanced within oral carcinoma in situ (CIS) foci, while it dynamically switches from CIS foci to the stromal space in squamous cell carcinoma (SCC). Because α-dystroglycan and integrin